Trump’s tariffs are a collision with economic reality
An often-overlooked aspect of protective tariffs is that returning manufacturing to the U.S. will inevitably raise the cost of consumer goods and burden domestic manufacturers.
Still no strategy: the federal silence on women’s health
A narrow lens on gynecology, pregnancy, and fertility has created a profound policy failure, contributing to stagnating progress in women’s health research, care, and infrastructure.
We need to design better systems to target hepatitis
We blazed the path and viral hepatitis followed. But it’s not too late to change course.
Health Canada plan forecasts a $1-billion spending drop by 2027-28
The department could also see a staff reduction of nearly 2,000 bureaucrats by 2028.
U.S. tariffs on pharmaceuticals could complicate an already complex supply chain
Drug companies could begin questioning whether to manufacture drugs or conduct clinical trials in Canada, says Life Sciences Ontario CEO.
Health minister won’t commit to tabling safe long-term care bill
The bill was initially promised by Justin Trudeau’s Liberal government following the thousands of deaths that occurred in long-term care during the initial waves of the COVID-19 pandemic.
A different ‘philosophy’ steers new drug pricing guidelines, says top PMPRB bureaucrat after contentious path to rule changes
Guideline changes became necessary after Justin Trudeau’s government chose to amend the Patented Medicines Regulations, a process beset with legal challenges and many delays.
Population planning must look beyond snapshot of fertility levels
There is no reason for panic about population decline. Instead, we should focus on promoting reproductive agency, and preparing for an aging society.
Turning the tables on ‘Positive Nutrition’
Positive Nutrition encourages individuals to view eating as an opportunity to nourish the body and mind by focusing on the abundance of nutrients and foods we should incorporate for optimal health.
G7 may have missed the mark on health, but Canada has a second chance to lead
If health is embedded into the G7’s work, the returns will be real and lasting. Otherwise, the cost of the missed opportunity will be measured not in dollars, but in lives.
